Hemab Therapeutics Holdings, Inc. Common Stock (COAG) is a publicly traded the market company. As of October 15, 2026, COAG trades at $29.96 with a market cap of $1.39B and a P/E ratio of 0.00. COAG moved +0.74% today. Year to date, COAG is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $23.00 to $55.42. Analyst consensus is strong buy with an average price target of $54.25. Rallies surfaces COAG's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for COAG combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $29.96 |
| Market Cap | $1.39B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $55.42 |
| 52-Week Low | $23.00 |
| Volume | 187.12K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
4 analysts cover COAG: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $54.25.